Evidence map›Paper›PMID 19951183›Full record

ArticleViral immunology2009

Attenuated and lethal variants of Pichindé virus induce differential patterns of NF-kappaB activation suggesting a potential target for novel therapeutics.

Gavin C Bowick, Susan M Fennewald, Lihong Zhang, Xianbin Yang, Judith F Aronson, Robert E Shope, Bruce A Luxon, David G Gorenstein, Norbert K Herzog

Abstract readComparative Study
In one paragraph

Article in Viral immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gavin C BowickCenter for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas 77555-0609, USA.
Susan M Fennewald
Lihong Zhang
Xianbin Yang
Judith F Aronson
Robert E Shope
Bruce A Luxon
David G Gorenstein
Norbert K Herzog

Funding

WRCE Nonhuman Primate CoreU54AI057156 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WALKER, DAVID H · 2003 to 2013
$102.6M
Biodefense Proteomics CollaboratoryU01AI054827 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI GORENSTEIN, DAVID G · 2003 to 2007
$6.1M
NIAID NIH HHS U54 AI057156NIAID NIH HHS UO1 AI054827
6 · The paper itself

Abstract

Lassa virus pathogenesis is believed to involve dysregulation of cytokines. We have previously shown nuclear factor-kappaB (NF-kappaB) inhibition using a BSL-2 model for Lassa fever. Here we further define the potential mechanism for NF-kappaB inhibition as involving increased levels of repressive p50/p50 homodimers, and suggest a novel therapeutic strategy that acts via modulation of host signaling.

Indexed as

AnimalsArenaviridae InfectionsCSK Tyrosine-Protein KinaseDefective VirusesDrug Delivery SystemsIn Vitro TechniquesMiceMonocytesNF-kappa BNF-kappa B p50 SubunitPhosphorylationPichinde virusProtein Processing, Post-TranslationalProtein TransportProtein-Tyrosine KinasesSignal TransductionCSK Tyrosine-Protein KinaseNF-kappa BNF-kappa B p50 SubunitProtein-Tyrosine KinasesRela protein, mousesrc-Family KinasesTranscription Factor RelA

Identifiers

PMID19951183
PMCPMC2883487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.